Home/Filings/4/0001600620-24-000021
4//SEC Filing

Habig Scott Michael 4

Accession 0001600620-24-000021

CIK 0001600620other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 4:33 PM ET

Size

6.3 KB

Accession

0001600620-24-000021

Insider Transaction Report

Form 4
Period: 2024-02-20
Habig Scott Michael
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2024-02-20+195,512508,231 total
  • Sale

    Common Stock

    2024-02-20$5.48/sh15,867$86,951492,364 total
Footnotes (2)
  • [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
  • [F2]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant.

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001938159

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:33 PM ET
Size
6.3 KB